CTI BioPharma gets Israel's approval for sale of cancer drug
July 23, 2014 at 13:58 PM EDT
CTI BioPharma Corp. has won approval from Israeli officials to distribute its Pixuvri drug for certain patients with cancer in Israel...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|